Blood basophils in lung cancer. by Anthony, H. M.
Br. J. Cancer (1982) 45, 209
BLOOD BASOPHILS IN LUNG CANCER
H. M. ANTHONY*
From the University Department of Immunology, The General Infirmary, Leeds
Received 10 August 1981 Accepted 25 October 1981
Summary.-Peripheral-blood basophils were counted, in thick smears, in samples
from patients with primary bronchial carcinoma, from patients in the same wards
and from normal individuals. The median counts for patients with other chest con-
ditions (15-5/4d) and bronchial-carcinoma patients free of tumour months to years
after resection (16/1l) did not differ from those for normal individuals (19/1,u), but
tumour-bearers showed higher counts (median 33/1z), 24/41 having counts above the
highest count in normal individuals (29/1l): P<0.002).
The highest values were in patients with squamous bronchial carcinoma, apparent-
ly reflecting spontaneous challenge of an anti-tumour immune response. In those
tested at the time of diagnosis, higher values in both lymphocyte and basophil counts
were related to surgical resectability.
BASOPHIL LEUCOCYTES are known to be
involved in immediate hypersensitivity
and the cutaneous basophil hypersensitiv-
ity (Jones-Mote) reaction, but their over-
all role is not clearly established. Like
mast cells, though of marrow origin,
basophils have receptors for IgE, IgG and
complement (Church & Holgate, 1980).
Basophils sensitized by cytophilic anti-
body release mediators, including hista-
mine and various peptides, on contact
with specific antigen, giving rise to some
of the symptoms of immediate hyper-
sensitivity. Slower release of mediators
occurs under the control of T lymphocytes
(Askenase, 1979). The induration typical
of delayed hypersensitivity is dependent
on mast cell and/or basophnil activity,and
results from the increased permeability of
capillary venules and the deposition of
fibrin (Dvorak et al., 1980). In nematode
systems basophil mediators, particularly
ECF-a (eosinophil chemotactic factor of
anaphylaxis) attract eosinophils and arm
them for more potent killing of the para-
sites (Kay, 1980). Basophils have been
reported in close contact with dying
cancer cells (Dvorak et al., 1973) when
cytotoxic activity was suggested.
Basophils represent less than 1% of
circulating leucocytes in normal individu-
als. Marked increases in some forms of
leukaemia can be detected in standard
differential counts, in spite of the wide
normal variation of the basophil count
obtained by this method (0-160/1l, Orfan-
akis et al., 1970). The chamber count
method (Moore & James, 1953) and
differential counts of 500 or more leuco-
cytes have been used in later studies,
leading to a contraction of the normal
range to 15-100/1l (Eastham, 1977). The
basophil count was reduced in acute
infection (Mitchell, 1958) probably on
account ofstress, since corticosteroids also
reduced the numbers of blood basophils
(Saavedra-Delgado et al., 1980) Blood
basophils increased during the recovery
phase after infection, often with an over-
shoot (Mitchell, 1958). Increased numbers
of blood basophils have also been reported
in ulcerative colitis (Juhlin, 1963) and in
cirrhosis, hypothyroidism and polycy-
thaemia (Wintrobe, 1974). Changes in
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basophil count with allergic conditions
have been morefirmlyestablished. Kimura
et al. (1973) showed raised basophil
counts before and low counts after an
attack of bronchial asthma, and this was
confirmed by Charles et al., (1979).
Hirsch et al. (1974) introduced a thick-
smear method for obtaining an absolute
basophil count directly, by counting
basophils in 2 ul of blood and halving the
result. Thick smears gave lower means and
showed less variability between tests than
the chamber counts. Using this method
Hirsch & Kalbfleich (1976) compared
blood basophil counts throughout the year
in atopics with severe pollen allergy and in
normal individuals. Mean basophil counts
in atopics in winter were marginally
higher (24.9 + l l/,ul) than in normal indi-
viduals (17.9 + 1.2/,ul). Atopics showed
increases in the pollen season (36.1 +
8.4/pl) which correlated well (r=0.82)
with the pollen count, but some increase
was also seen in normal individuals
(20-8 + 13/,ul) during the pollen season.
We report increases in the blood baso-
phil count in patients with active bronch-
ial carcinoma, using the thick-smear
method.
MATERIALS AND METHODS
Blooddonors.-Atotal of115 blood samples
were examined. Sixty-five were from 63
patients with primary bronchial carcinoma,
taken at the time of diagnosis or during
follow-up (see Table I). Thirty-two were from
patients from the same wards suffering from
chronic obstructive bronchitis (5), tubercu-
losis (3), other chest infections (16), ischaemic
or rheumatic heart disease (7), cardiac
failure (10), bronchial asthma (1) and other
malignancies (3). Several had multiple diag-
noses. Bronchial carcinoma was in the
differential diagnosis in 11 cases; in 3 it has
not been finally eliminated. Eighteen samples
were from 7 normal laboratory staff.
Method.-Venous blood was taken in the
morning and anticoagulated with EDTA.
Thick smears were prepared on clean slides
within 2 h by pipetting 2 ,1 ofblood on to the
slide with a circular motion to form a smear
7-5 mm in diameter (Hirsch et al., 1974).
Smears were air-dried, fixedin fresh methanol
overnight, stained with filtered 0 2% tolui-
dine blue in 2.5% A12(SO4)3 for 5 min,
rinsed with water and absolute alcohol and
cover-slipped from the third xylene rinse
(Hirsch et at., 1974). All the basophils in each
thick smear were counted and the results
halved to give the count per pl. Two or more
thick smears were counted for each sample.
White cell counts and differential cell
counts (400 cells standard, minimum 200)
were also performed on most samples
(Table I).
Statistics.-Differences between groups
were assessed using the Mann-Whitney
U-test and correlations using Spearman's
rank correlation coefficient.
TABLE I.-Blood basophil counts in patients with primary bronchial carcinoma. Number
oftests
Total a
tests Squamous
Histopathology
Oat-cell Adenoca.
Total
Undiff. Not known patients
On diagnosis 36
Inoperablea 9 (3)b 0 0 0
Later resected 10e 2 4 2
6-8 weeks p.o. 6
Post-explorationa 1 0 0 0
Post-resection 4c (2) 0 0 1 (1)
10monthsto 11 years p.o. 23
Post-explorationa 0 0 0 0
Post-resection
Recurreda 3d 0 0 0
Possibly recurring 4d (2) 0 0 0
Clear 14 (4) 0 0 1 (1)
Total tests 65
Total patients 43 2 4 4
a Tumour-bearers.
b Numbers of tests lacking white-cell count and/or differential count in parentheses.
cc, dd Indicates a case in common.
36c
9 (1)
0
6c
0
0
18
18
1
5
1
3d
4d
15
22
0
0
0
10 63
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FIG. 1.-Peripheral-blood basophil count in
normal individuals, in non-malignant chest
patients, and in patients with primary
bronchial carcinoma tested at diagnosis, 6
weeks after operation and 10 months to 11
years after operation. 0 No tumour (or
believed to be tumour-free); C bronchial
carcinoma not excluded; O) recurrence sus-
pected; * primary bronchial carcinoma
pretreatment, inoperable or recurrent.
RESULTS
Thick smears made from the same
sample gave consistent results. In counts
ranging from 1 to 110/1u the mean
standard deviation was 3-7 + 0-25 for
115 samples. In 18 tests on 7 normal
individuals counts ranged from 9 to 29
with a median of 19/pl (Fig. 1).
The median values from samples from
lung-cancer patients clinically free of
disease after resection (16/,ul all, 20/,l
squamous > 10 months p.o.) and from
patients without malignant disease (13/1l)
were similar, though the spread was wider
in the latter group (Fig. 1); the highest
value being shown by the only patient
suffering from bronchial asthma (48/,ul).
Bronchial carcinoma-bearing patients (sol-
id symbols, Fig. 1) tended to show higher
values (median 33, range 5 5-110) sig-
nificantly higher than the normal indi-
viduals (P < 0 002), other patients (P <
0.001) and the resected patients free of
disease (P < 0-001). In tumour bearers,
values were higher than the highest
normal value in 15/23 with squamous
carcinoma, 2/8 with other types, and 7/10
cases of lung cancer without histopatho-
logical confirmation.
Of the 6 patients tested 6-8 weeks after
operation, normal values were recorded
for each of the 5 who had had resections
but not for the patient who had undergone
exploratory thoracotomy (Fig. 1). Counts
tended to be high in patients with re-
current disease (Fig. 1) and in patients
bearing tumours of other types (renal
carcinoma 31/,l, resected oesophageal
carcinoma 18/1zl, non-Hodgkin's lymph-
oma 55.3//Al)
Two patients with squamous carcinoma
were each tested twice. In one a basophil
count of 30 3 +5.0/pl on diagnosis fell to
12.3 +4.6/)ul 6 weeks after resection; in
the other a value of 17 +4.0/pl 5 years
after resection, when recurrence was sus-
pected, rose to 3300±07/,ul 4 months
later, when recurrence was explicit.
In general, basophil counts were not
related to total leucocyte counts, though
significant correlation was seen in in-
operable cancer patients without histologi-
cal confirmation (n= 9, r= 0-68, P < 0.05)
and in other chest patients with WBC
counts under 10 x 109/1 (r=0 59,P< 0 01).
There was a tendency throughout for the
numbers of basophils and monocytes to
correlate, significant only in tumour-
bearers (Table II) and in other chest
patients without leucocytosis (r= 0-53,
P < 0 01). A suggestion of correlation
between basophils and eosinophils was
noted in bronchial carcinoma-bearing
patients and in resected patients free of
disease (Fig. 2) but not in the othergroups.
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TABLE II.-Median values for leucocyte, lymphocyte, monocyte and eosinophil counts/,ul
and correlations with basophil counts in patients with primary bronchial carcinoma
Leucocytes
x 10-3 Lymphocytes Monocytes Eosinophils Basophils
f
n Median Ra Median R Median R Median R n Median
All types
Tumour-bearersb
Inop. at diagnosis
Later resected
Squamous Ca.
Tumour-bearers
Inop. at diagnosis
Later resected
Post-resection (> 10
months), clear
7 4
7 9
7.3
7 3
7*0
7-2
0 48*C 1449
1260
1728**d
0-22
0-23 665
589
810
1420 0-29 662
993 573
1589*d 767
0-41** 135
189
129
0 37
10 7-3 -0-18 1776*d 0 04 447 0-24
116
42
135
0.35** 41 33
18 28
18 31
0 35 23 33
9 23
10 37 5**d
142 0-36 14 20
*P<O.01, **P<0-05.
a Spearman's rank correlation coefficient for correlation with the basophil count.
b Includes patients post-exploration and recurred after resection (see Table I).
c Reduced (0- 32, non-sig.) when patients with a high white-cell count (> lO x 109/1) excluded.
d For comparison with "Inop. at diagnosis" by Mann-Whitney U-test.
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FIG. 2.-Peripheral-blood basophils and eosinophils in bronchial carcinoma patients bearing tumour
(r =0 35, P < 0 05, solid symbols) and clinically free of recurrence after resection (r = 0-36, non-sig.
open symbols). A, on diagnosis of squamous carcinoma: A, subsequently resected; 0, inoperable.
B, On diagnosis: 0, inoperable, histopathology not known; A, *, V, adenocarcinoma, oat-cell
carcinoma, large-cell undifferentiated carcinoma (respectively) subsequently resected. C,
Squamous-cell-carcinoma patients tested duringfollow-up: A, resected, clinically clear; A, resected,
recurring; V, not resected.
The highest basophil counts were seen
in tumour-bearing patients with squamous
bronchial carcinoma (Fig. 2A, C). Counts
were not related to the differentiation of
the tumour. Pretreatment samples from
patients with subsequently resected squa-
mous carcinomas tended to have higher
counts of basophil, lymphocytes and
monocytes than from those who were
inoperable (Table II). If basophil counts
were plotted against lymphocyte counts
(Fig. 3) an arbitrary line could be drawn
giving almost complete separation be-
tween the inoperable patients (below and
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TABLE III.-Results oftests in 1Opatients with non-squamousprimarybronchialcarcinoma
Estimates ofcells/il
1. Adenoca
2. Adenoca m/d
3. Adenoca p/d
4. Adenoca
5. Large-cell
undifferentiated ca
6. Large-cell
undifferentiated ca
7. Small (oat-) cell ca
8. Small (oat-) cell ca
9. Large-cell
undifferentiated ca
10. Large-cell
undifferentiated ca
^ 5 ~~~Basophil Tum(
Lymphocyte Monocyte Eosinophil count/jul beari
1739 884 211 27-8+ 1-8
1790 1252 93 47 5+5-7
735 200 121 6-5+3-5
1903 774 22 23-0+2-8
2166 358 122 13-0+2-8 Yes
132 362 28 15-3+ 5_ 3
6 2945 1053 389 49 5+4-2
2198 1217 141 5-5+_0
ND ND ND 14+ 3 No
ND ND
to the left) and those subsequently
resected (above and to the right). When
the same line was applied to the other
plots, 17/18 normal samples and 25/29
from other chest patients fell below and to
the left of the line: the exceptions in-
cluded 2 patients in whom the diagnosis of
bronchial carcinoma has not been finally
excluded, and 1 with bronchial asthma.
The pattern of basophil/monocyte plots
15
.our
ing Tested
On diagnosis, later
resected
6 weeks post-resection
ND 19+4 No 10 years post-resection
was similar; an arbitrary line again
separated most of the operable from the
inoperable cases, but separation was less
distinct and 9/27 other chest patients gave
values above and to the right of the line
including the same 3 patients and 6
others, all with infections. The pattern
was less evident on basophil/eosinophil
plots (Fig. 2A).
Ten tests were performed in patients
120r
A
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with other types of bronchial carcinoma
(Table III, Fig. 2). Patients with adeno-
carcinomas and oat-cell carcinomas
showed raised values but all 4 counts in
patients with large-cell undifferentiated
carcinomas (2 tumour bearers) were under
20//. The arbitrary dividing lines on
basophil/lymphocyte/monocyte plots did
not predict surgical resectability in these
patients.
DISCUSSION
This study has shown raised basophil
counts in peripheral blood of most tumour-
bearing patients with bronchial carcin-
oma, particularly those with squamous
carcinoma. Higher counts were also noted
in 3 patients in whom the diagnosis of
bronchial carcinoma has not been finally
excluded, but in only 2 patients from the
same wards without malignant disease,
one of whom was the only case of bronch-
ial asthma.
OnlY one other group has reported
studies of blood basophils in cancer
patients (Gracheva et al., 1976; Sergeev
et al., 1977) and they found increased
degranulation but no consistent differ-
ences in the numbers of blood basophils in
patients with carcinoma of the stomach.
Degranulation was particularly marked in
patients witih more advanced disease
(Sergeev et al., 1977). The fewx patients
who showed positive responses (6/56) in
delayed hypersensitivity reaction skin
tests with a membrane-antigen prepara-
tion from stomach carcinoma tended to
have higher basophil counts and more
degranulation of basophils than patients
who did not respond. Controls in their
study gave higher values (35.1 + 2.7/tiJ)
than in ours (median 19/pu, mean 199+
7-0) consistent with the differences re-
ported by Hirsch et al. (1974) for the
chamber method (which thev used) and
the thick-smear method. Controls in our
study gave values very close to those of
Hirsch & Kalbfleich (1976) for non-atopic
individuals (17.9+ 1P2 winter, 20 8 + 1*3
summer), using the thick-smear method.
The only- well-documente(d reports of
increased circulating basophils in mani
(except in the leukaemias) are in patients
recovering from infection (Mitchell, 1 958),
with tulcerative colitis (Juhlin, 1963), an(l
those with severe atopic disease, all con-
ditions with immunological components.
In this study increased basophils in
squamous-carcinoma patients were not
associated with a raised leucocyte count,
nor were basophil counts altered in most
of the other patients with chronic bronch-
itis, tuberculosis and other infections.
Tissue infiltration with basophils occurs
in the relatively transient, cutaneous
basophil hypersensitivity, but less in
classical delayed hypersensitivity, appar-
ently because of an inhibitory effect
(Dvorak et al., 1980). Basophils were
noted in close contact with dying cells of
the Line I hepatoma in immunized
guinea-pigs (Dvorak et al., 1973) and were
prominent in the cellular infiltrate in the
skin-window technique when autologous
breast-tumour sections were applied in
strongly reactive patients (Black & Leis,
1971). Eosinophil (Kolb & Muller, 1979),
mononuclear (Joachim et al., 1976) and
macrophage (Kolb & Muller, 1979) infiltra-
tion of lung carcinomas were each re-
ported to be associated with a better
prognosis, but the significance of mast
cells and basophils has not been investi-
gated. Blood basophilia was noted in
guinea-pigs rejecting a transplanted hepa-
toma (Dvorak et al., 1.973).
With some techniques, cell-mediated
tumour immunity may be detected in
vitro from earlyT on in tumour development
to manvy years after resection (Halliday,
1.977). Antigen, continuously shed from
tumour cells, was detectable in the serunm
of tumour bearers, but the concentration
fell rapidly after tumour excision (Bald-
win et al., 1973). The raised basophil
counts in patients with active lung cancer
probably reflect naturally occurring chal-
lenge of an anti-tumour immune re-
sponse by circulating antigen. This inter-
pretation is supported by the normal
counts in patients 6 weeks after resection
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(but not after exploration) and in resected
patients free of recurrence.
Lymphocytosis occurred in mice during
rejection, and induced lymphocytosis was
the earliest effective anti-tumour adjuvant
therapy (Murphy, 1926). Reactive lymph-
ocytosis (Anthony et al., 1975) and in-
creased lymphocyte mitogenesis (Chretien
et al., 1973) have been reported in some
lung-cancer patients, returning to normal
levels after lung resection.
The correlation noted between a func-
tion of the lymphocyte and basophil
counts and resectability may be evidence
that the resistance mechanisms they
reflect are exerting some control over
tumour extension as indicated for lymph-
ocytes in a previous study (Anthony et al.,
1981). However, it could also result from
earlier diagnosis in patients with chronic
basophil release due, for instance, to
exacerbation of the presenting dyspnoea
by a degree of bronchospasm due to
histamine (Bhat et al., 1976).
The numbers of basophils in the blood
of lung-cancer patients showed some
correlation with the numbers of mono-
cytes, and of eosinophils, stronger and
more consistent in each case than that
with the overall leucocyte count, on which
they would be unlikely to depend. The
correlation between basophils and eosino-
phils was not seen in normal individuals
or in the diverse group of control patients,
though it could have been missed because
of the low counts with their relatively
large errors of enumeration. The numbers
of basophils and eosinophils correlated
similarly in lung-cancer patients bearing
tumours and in those believed to be free
ofdisease after resection, significant in the
former group. The correlation could result
from a common homoeostatic mechanism
controlling levels of both types of cell, or
from influences of one cell type on the
circulating levels of the other. Little is
known about the control of basophils, or
about their lifespan, since the only
evidence has been from studies of ab-
normal basophils. Basophil mediators are
reported to attract eosinophils to the site
of nematode infestation and arm them for
more potent killing ofthe nematodes (Kay,
1980). It is possible that the link between
the numbers of circulating basophils and
eosinophils in lung cancer patients lies in
a similar interaction in relation to the
tumour, since eosinophil infiltration of
tumours was associated with both blood
eosinophilia and with a better prognosis
(Kolb & Muller, 1979).
Using the thick-smear method for the
blood basophil count, which is a relatively
simple test, we found raised basophil
counts in most patients with resectable
squamous-cell carcinomas and in some
patients with carcinomas of other types.
The data suggest that a normal basophil
count is uninformative but that a raised
basophil count in patients without major
allergy should be another factor to
consider in the differential diagnosis of
carcinoma of the bronchus and possibly
with carcinomas at other sites.
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